Upstream Bio, Inc. (NASDAQ:UPB) People

Upstream Bio, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniella Beckman
Other companies: Blueprint Medicines Corp (Director · Since at least Dec 8, 2021); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Translate Bio Inc (Director · Jun 18, 2019 – Sep 14, 2021 · Past)
Member, Board of Directors · Since at least Oct 10, 2024
Michael Gray
Other companies: POINT Biopharma Global Inc (Director · Jul 7, 2020 – Jul 7, 2020 · Past); Enliven Therapeutics, Inc. (CFO & COO · Mar 11, 2020 – Feb 22, 2023 · Past); X4 Pharmaceuticals, Inc. (President, CEO and CFO, Director · Nov 15, 2017 – Nov 27, 2018 · Past)
CFO and COO · Since at least Oct 10, 2024
Harold Edward Fleming
Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); CRISPR Therapeutics AG (Director · Since at least Jun 10, 2021)
Director · Since at least Oct 10, 2024
Marcella Kuhlman Ruddy
Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Tectonic Therapeutic, Inc. (Chief Medical Officer · Since at least Jun 20, 2024)
Chief Medical Officer, Tectonic Therapeutic · Since at least Oct 10, 2024
Edd Fleming
Other companies: Sionna Therapeutics, Inc. (Director · Since at least Nov 5, 2026)
Executive Vice President, Enavate Sciences · Since at least Nov 5, 2026
Aaron DeykinChief Medical Officer & Head of R&D · Since at least Jun 16, 2026
Adam HoughtonChief Business Officer · Since at least Jun 16, 2026
Allison AmbroseGeneral Counsel · Since at least Dec 16, 2024
Amy IannelliVice President, Finance · Since at least Nov 5, 2026
Ashish KalraVice President, Translational Research · Since at least Jun 5, 2025
Christopher SilvaVice President, Supply Chain · Since at least Nov 5, 2026
Ken AdamsSenior Vice President, Clinical Operations & Medical Writing · Since at least Nov 4, 2026
Liam RatcliffeHead of Biotechnology, Access Industries · Since at least Nov 5, 2026
Marie SanchiricoVice President, Medical Affairs · Since at least Nov 5, 2026
Meggan BuckwellDirector, Corporate Communications and Investor Relations · Since at least Mar 1, 2026
Mersedeh MiraliakbariSenior Vice President, Regulatory Affairs and Quality · Since at least Nov 5, 2026
Mike GrayChief Financial Officer and Chief Operating Officer · Since at least Sep 17, 2026
Parika PetaipimolVice President, Technical Operations · Since at least Nov 5, 2026
Rand SutherlandChief Executive Officer · Since at least Aug 11, 2026
Ron RenaudChair, Board of Directors · Since at least Nov 4, 2026
Stacy PriceChief Technology Officer · Since at least May 20, 2025
Sumathi SivapalasingamVice President & Head of Clinical Development · Since at least Nov 5, 2026